Published in Hepatitis Weekly, September 7th, 2009
"At 118 sites, patients who had HCV genotype 1 infection and who had not previously been treated were randomly assigned to undergo 48 weeks of treatment with one of three regimens: peginterferon alfa-2b at a standard dose of 1.5 mu g per kilogram of body weight per week or a low dose of 1.0 mu g per kilogram per week, plus ribavirin at a dose of 800 to 1400 mg per day, or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.